Related references
Note: Only part of the references are listed.Blockade of 6-phosphogluconate dehydrogenase generates CD8+ effector T cells with enhanced anti-tumor function
Saeed Daneshmandi et al.
CELL REPORTS (2021)
The pancreatic cancer genome revisited
Akimasa Hayashi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
The metabolism of cancer cells during metastasis
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2021)
A covalent small molecule inhibitor of glutamate-oxaloacetate transaminase 1 impairs pancreatic cancer growth
Tomohiro Yoshida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Carcinogenesis of Pancreatic Ductal Adenocarcinoma
Peter Storz et al.
GASTROENTEROLOGY (2020)
Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
Maria Victoria Recouvreux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis
Matthew E. Bechard et al.
NATURE COMMUNICATIONS (2020)
Targeting Metabolic Plasticity and flexibility Dynamics for Cancer Therapy
Sarah-Maria Fendt et al.
CANCER DISCOVERY (2020)
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Kirsten L. Bryant et al.
NATURE MEDICINE (2019)
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
Conan G. Kinsey et al.
NATURE MEDICINE (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Vinod P. Balachandran et al.
GASTROENTEROLOGY (2019)
Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases
Matthew E. Bechard et al.
ONCOGENE (2018)
Minimal functional driver gene heterogeneity among untreated metastases
Johannes G. Reiter et al.
SCIENCE (2018)
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
Alvin P. Makohon-Moore et al.
NATURE GENETICS (2017)
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
Oliver G. McDonald et al.
NATURE GENETICS (2017)
Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis
Jae-Seok Roe et al.
CELL (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer
Huai-Qiang Ju et al.
CANCER LETTERS (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
Jurre J. Kamphorst et al.
CANCER RESEARCH (2015)
Oxidative stress inhibits distant metastasis by human melanoma cells
Elena Piskounova et al.
NATURE (2015)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Christine A. Iacobuzio-Donahue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Immortalizing the complexity of cancer metastasis - Genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy
EE Embuscado et al.
CANCER BIOLOGY & THERAPY (2005)